# SEC Litigation Release LR-25134

> Civil enforcement action · 2021-07-02

## Defendants

Lambert Vander Tuig, Ben Schactschneider, Capital Development Resources f/k/a Biosynetics, and Biosynetics Management, and Relief Defendant Galileo Labs, Inc.

## Related filings

SEC Complaint


## Key facts

- **Release number:** LR-25134
- **Release date:** 2021-07-02
- **Defendants:** Lambert Vander Tuig, Ben Schactschneider, Capital Development Resources f/k/a Biosynetics, and Biosynetics Management, and Relief Defendant Galileo Labs, Inc.

## Primary sources

- SEC HTML release: https://www.sec.gov/litigation/litreleases/2021/lr25134.htm
- Litigation releases index: https://www.sec.gov/litigation/litreleases

## What this is

SEC Litigation Releases are the canonical "civil enforcement" docket. The SEC files civil actions in federal court against individuals and entities for securities-law violations — fraud, insider trading, Ponzi schemes, registration violations, misleading disclosures, market manipulation. Each release announces a filing, a settlement, or a final judgment. Activist funds, plaintiff lawyers, and investigative journalists use this archive as the most-comprehensive index of US securities enforcement.

## Citation

> US Securities and Exchange Commission, Litigation Release LR-25134 (2021-07-02), Lambert Vander Tuig, Ben Schactschneider, Capital Development Resources f/k/a Biosynetics, and Biosynetics Management, and Relief Defendant Galileo Labs, Inc.. Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/sec-litigation/25134.

---

*[SEC litigation releases dataset](/datasets/sec-litigation-releases) · CC0 1.0*